Verotoxin IIB Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of Verotoxin IIB monoclonal antibodies for research focused on understanding this potent toxin. Verotoxin IIB Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Verotoxin IIB, produced by certain strains of Escherichia coli, is known for its ability to inhibit protein synthesis in eukaryotic cells, leading to cell death and contributing to severe gastrointestinal diseases. Understanding the mechanisms of Verotoxin IIB is crucial for developing therapeutic strategies and interventions against infections caused by pathogenic E. coli. The study of Verotoxin IIB also provides insights into the broader implications of bacterial toxins in human health. Researchers can explore the molecular pathways and cellular responses associated with Verotoxin IIB activity using specific detection methods. Advanced research techniques allow for detailed examination of toxin-cell interactions and disease progression patterns. Investigating Verotoxin IIB mechanisms contributes to better understanding bacterial pathogenesis and potential treatment approaches. Santa Cruz Biotechnology monoclonal antibodies support the scientific community in advancing microbiology and infectious disease research through reliable and specific detection of Verotoxin IIB.